IMM 1.49% 34.0¢ immutep limited

We are getting near the pointy end of research into Efti's...

  1. 25,397 Posts.
    lightbulb Created with Sketch. 1377
    We are getting near the pointy end of research into Efti's effectiveness in assisting treatment for various cancer indications....
    In combination with keytruda it is showing better results with more successful outcomes for patients than keytruda alone
    in trials conducted sofar....Even signs of a combo that can negate the need for chemotherapy in certrain cases....
    To be brutally honest, there is gonna need to be a major reversal in trial data over the next few months for Efti to fall over...
    We have much to look forward to here and to be honest once again there is cause for confidence...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.